ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
Copyright: © 2022 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Frequent association of vitiligo with autoimmune endocrine diseases: primary data of the Russian cohort of adult patients
About authors
1 Endocrinology Research Centre, Moscow, Russia
2 Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia
3 Peoples’ Friendship University of Russia, Moscow, Russia
Correspondence should be addressed: Nurana F. Nuralieva
Dmitriya Ulyanova, 11, Moscow, 117292, Russia; ur.xednay@anarunn
About paper
Funding: this work was supported by Foundation for Scientific and Technological Development of Yugra (agreement No 2022-05-01/2022).
Author contribution: Nuralieva NF — endocrinology examination, data acquisition, statistical analysis, literature analysis, manuscript writing, preparation of the article for publication; Yukina MYu — study concept development, endocrinology examination, manuscript editing; Troshina EA — approval of the study concept and the final text of the manuscript; Zhukova OV — approval of the final text of the manuscript; Petrov VA — dermatology examination, data acquisition, literature analysis; Volnukhin VA — approval of the study concept, dermatology examination, manuscript editing and approval of the final text.
Compliance with ethical standards: the study was approved by the Ethics Commitee of the Endocrinology Research Centre (protocol № 17 of 27 September 2017); the informed consent was submitted by all patients.
Received: 2022-09-29
Accepted: 2022-10-13
Published online: 2022-10-29
|
Figure. The prevalence of autoimmune endocrine disorders in the cohort of adult patient with vitiligo initially monitored in the Endocrinology Research Centre
Table 1. Characteristics of study participants
Note: М — male, F — female.
Table 2. The prevalence of AEDs and the AITDs and pancreatic islet autoimmunity marker antibodies positivity in female and male vitiligo patients initially monitored in the Endocrinology Research Centre
Note: М — male, F — female.
Table 3. The prevalence of AEDs and antibodies positivity in female and male vitiligo patients initially monitored in the Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
Note: М — male, F — female.
